Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 27, 2023

BUY
$3.14 - $5.04 $50,494 - $81,048
16,081 New
16,081 $50,000
Q2 2023

Jul 18, 2023

BUY
$4.6 - $7.64 $57,099 - $94,835
12,413 Added 366.17%
15,803 $81,000
Q1 2023

Apr 13, 2023

BUY
$2.79 - $6.27 $9,458 - $21,255
3,390 New
3,390 $17,000
Q4 2021

Jan 28, 2022

BUY
$6.16 - $12.07 $6 - $12
1 New
1 $0

Others Institutions Holding OCUL

About OCULAR THERAPEUTIX, INC


  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $526M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.